Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 4/20 | 0.53 |
| ▸ | CYP1B1 | Q16678 | 4/20 | 0.53 |
| ▸ | MAPT | P10636 | 4/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.50 |
| ▸ | CRHBP | P24387 | 1/20 | 0.49 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.46 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 3/20 | 0.43 |
| ▸ | RAB9A | P51151 | 3/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29110557 | 0.89 | CYP1A1 (0.38) | CYP1A1CYP1B1MAPTALDH1A1KMT2A | |
| SCHEMBL19416799 | 0.83 | CYP1A1 (0.42) | CYP1A1CYP1B1MAPTALDH1A1KMT2A | |
| SCHEMBL31403390 | 0.83 | CYP1A1 (0.47) | CYP1A1CYP1B1MAPTALDH1A1KMT2A | |
| SCHEMBL6216044 | 0.83 | ALDH1A1 (0.40) | CYP1A1CYP1B1MAPTALDH1A1KMT2A | |
| SCHEMBL7927094 | 0.83 | CYP1A1 (0.39) | CYP1A1CYP1B1MAPTALDH1A1KMT2A | |
| SCHEMBL11270049 | 0.83 | CYP1A1 (0.53) | CYP1A1CYP1B1MAPTALDH1A1KMT2A | |
| SCHEMBL8910888 | 0.82 | CYP1A1 (0.56) | CYP1A1CYP1B1MAPTALDH1A1KMT2A | |
| SCHEMBL1030266 | 0.82 | POLB (0.47) | CYP1A1CYP1B1MAPTALDH1A1KMT2A | |
| SCHEMBL57085 | 0.81 | NFE2L2 (0.58) | CYP1A1CYP1B1MAPTCYP19A1CYP1A2 | |
| SCHEMBL8502492 | 0.80 | CYP1A1 (0.56) | CYP1A1CYP1B1MAPTALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-210942955-U | Packaging bag of moisture curing polymer | 江苏科幸新材料有限公司 | 2020-07-07 | — | — | CN | claimed |
| CN-104761537-B | Preparation method of beta-chloro-1,3-dithiane derivative | 兰州大学 | 2017-02-15 | — | — | CN | claimed |
| CN-104761537-A | Preparation method of beta-chloro-1,3-dithiane derivative | UNIV LANZHOU | 2015-07-08 | — | — | CN | claimed |
| JP-2006518738-A | — | — | 2006-08-17 | — | — | JP | claimed |
| EP-1594847-A2 | SUBSTITUTED AZOLE DERIVATIVES AS THERAPEUTIC AGENTS | Transtech Pharma, Inc. (US) | 2005-11-16 | — | — | EP | claimed |
| WO-2004071447-A9 | SUBSTITUTED AZOLE DERIVATIVES AS THERAPEUTIC AGENTS | TRANSTECH PHARMA INC (US) | 2005-10-13 | — | — | WO | claimed |
| US-20040192743-A1 | Substituted azole derivatives as therapeutic agents | TRANSTECH PHARMA, INC. | 2004-09-30 | — | — | US | claimed |
| WO-2004071447-A2 | SUBSTITUTED AZOLE DERIVATIVES AS THERAPEUTIC AGENTS | TRANSTECH PHARMA INC. (US) | 2004-08-26 | — | — | WO | claimed |
| EP-0787750-B1 | Poly(alkylethylene) structural isomers | BOREALIS GMBH (AT) | 2003-05-14 | — | — | EP | claimed |
| US-12030974-B2 | Composition for forming block copolymer layer for formation of microphase-separated pattern | NISSAN CHEMICAL CORPORATION (JP) | 2024-07-09 | — | — | US | disclosed |
| US-12030974-B2 | Composition for forming block copolymer layer for formation of microphase-separated pattern | NISSAN CHEMICAL CORPORATION (JP) | 2024-07-09 | — | — | US | disclosed |
| US-20230399300-A1 | METHODS OF SYNTHESIZING 2-[4-[(2,3,4-TRIMETHOXYPHENYL)METHYL] PIPERAZIN-1-YL]ETHYL PYRIDINE-3-CARBOXYLATE | IMBRIA PHARMACEUTICALS, INC. | 2023-12-14 | — | — | US | disclosed |
| US-11780811-B2 | Methods of synthesizing 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate | IMBRIA PHARMACEUTICALS, INC. (US) | 2023-10-10 | — | — | US | disclosed |
| US-20230280654-A1 | UPPER FILM-FORMING COMPOSITION AND METHOD FOR PRODUCING PHASE-SEPARATED PATTERN | NISSAN CHEMICAL CORPORATION (JP) | 2023-09-07 | — | — | US | disclosed |
| EP-0787750-A2 | Poly(alkylethylene) structural isomers | PCD-Polymere Gesellschaft m.b.H. (AT) | 1997-08-06 | — | — | EP | disclosed |
| EP-0574510-A4 | NEOLIGNAN DERIVATIVES AS PLATELET ACTIVATING FACTOR RECEPTOR ANTAGONISTS AND 5-LIPOXYGENASE INHIBITORS | INNOVATIVE TECH CENTER (US) | 1994-07-06 | — | — | EP | disclosed |
| US-5326489-A | Sulfonated polymer | NIPPON SHOKUBAI CO., LTD. (JP) | 1994-07-05 | — | — | US | disclosed |
| EP-0523300-B1 | Electrorheological fluids | NIPPON CATALYTIC CHEM IND (JP) | 1994-01-19 | — | — | EP | disclosed |
| EP-0574510-A1 | NEOLIGNAN DERIVATIVES AS PLATELET ACTIVATING FACTOR RECEPTOR ANTAGONISTS AND 5-LIPOXYGENASE INHIBITORS | CENTER FOR INNOVATIVE TECHNOLOGY (US) | 1993-12-22 | — | — | EP | disclosed |
| EP-0523300-A1 | Electrorheological fluids | NIPPON SHOKUBAI KAGAKU KOGYO CO. LTD. (JP) | 1993-01-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040192743-A1 | Substituted azole derivatives as therapeutic agents | PTPRS, PTPRO, PTPRJ | CYP1A1 697/4885CYP1B1 345/4885MAPT 3558/4885 |
| US-11780811-B2 | Methods of synthesizing 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate | TET3, TET2, TET1 | CYP1A1 490/4885CYP1B1 2015/4885MAPT 4224/4885 |
| US-20230399300-A1 | METHODS OF SYNTHESIZING 2-[4-[(2,3,4-TRIMETHOXYPHENYL)METHYL] PIPERAZIN-1-YL]ETHYL PYRIDINE-3-CARBOXYLATE | TET3, TET2, TET1 | CYP1A1 490/4885CYP1B1 2015/4885MAPT 4224/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.